Press Releases about Roivant Sciences Ltd
Roivant Provides Update on Graves’ Disease Development Program
September 09, 2024
From Roivant Sciences
Via GlobeNewswire
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
From Roivant Sciences
Via GlobeNewswire
From Covant Therapeutics
Via GlobeNewswire
Roivant Announces Completion of Redemption of its Outstanding Warrants
September 11, 2023
From Roivant Sciences
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|